A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 44,900 shares of LEXX stock, worth $110,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,900
Previous 48,800 7.99%
Holding current value
$110,005
Previous $135,000 0.74%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$2.58 - $4.09 $10,062 - $15,951
-3,900 Reduced 7.99%
44,900 $136,000
Q2 2024

Jul 19, 2024

BUY
$1.99 - $4.0 $18,407 - $37,000
9,250 Added 23.39%
48,800 $135,000
Q1 2024

Apr 22, 2024

BUY
$1.29 - $6.25 $51,019 - $247,187
39,550 New
39,550 $143,000

Others Institutions Holding LEXX

About Lexaria Bioscience Corp.


  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $14.6M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.